2018-05-14T19:28:39-05:00 2017-06-30 910189318 Moss Adams LLP 999 Third Avenue Suite 2800 Seattle WA 98104 990 2016-07-01 911019655 Bloodworks BLOO 2062926500 921 Terry Avenue Seattle WA 981041256 ROBERT GLEASON CHIEF FINANCIAL OFFICER 2066896680 2018-05-07 1 Wendy Campos P00448102 2063026500 2018-05-07 2016 2022-09-23 18:48:47Z DR JAMES AUBUCHON 921 Terry Avenue Seattle WA 981041256 200026207 0 X WWW.BLOODWORKSNW.ORG X 1944 WA SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION & EXCELLENCE IN BLOOD, MEDICAL & LAB SERVICES. 21 20 1106 2470 0 0 1510536 1421459 175586838 175947671 3615948 14070815 149530 224538 180862852 191664483 552319 508978 0 0 74814392 75401590 0 77421 1579193 105433927 105207112 180800638 181195101 62214 10469382 140073386 147198662 54481038 48339588 85592348 98859074 X SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION AND EXCELLENCE IN BLOOD, MEDICAL AND laboratory SERVICEs IN PARTNERSHIP WITH OUR COMMUNITY. 0 0 147272177 149545 165004594 Your Community Resource For Lifesaving BloodWITH THE HELP OF 230,000 REGISTERED DONORS AND VOLUNTEERS IN THE REGION, BLOODWORKS COLLECTS ABOUT 800 UNITS OF BLOOD EACH DAY. ALL BLOOD RECEIVES IMMEDIATE, COMPREHENSIVE TESTING SO THAT IT CAN BE AVAILABLE TO MORE THAN 90 HOSPITALS USUALLY IN LESS THAN 24 HOURS AFTER DONATION. BLOODWORKS OPERATES 12 DONOR CENTERS AND THEIR MOBILE UNITS TRAVEL TO HUNDREDS OF BLOOD DRIVES EVERY MONTH AT WORK SITES, SCHOOLS, PLACES OF WORSHIP, AND OTHER COMMUNITY LOCATIONS THROUGHOUT THE PACIFIC NORTHWEST .See Schedule O for continued description of activity.TRANSFUSION MEDICINE EXPERTSBLOODWORKS' OPERATIONS ARE AN ESSENTIAL COMPONENT OF THE REGION'S HEALTHCARE SYSTEM PROVIDING A SAFE, STABLE AND COMMUNITY-BASED BLOOD SUPPLY FOR NORTHWEST COMMUNITIES. BLOODWORKS' PHYSICIANS ARE TRANSFUSION EXPERTS, AVAILABLE TO HOSPITALS 24/7 FOR CONSULTATION ON CHALLENGING CASES. BLOODWORKS' TRANSFUSION SAFETY OFFICERS WORK IN HOSPITALS TO ENSURE THAT BLOOD TRANSFUSIONS ARE PERFORMED ACCORDING TO CURRENT BEST MEDICAL PRACTICES.PATIENT SERVICESOur TEAM OF PHYSICIANS AND NURSES IS RECOGNIZED AS PREMIER SPECIALISTS IN THE THERAPEUTIC APPLICATION OF APHERESISPROCEDURES THAT SEPARATE BLOOD INTO ITS COMPONENTS. THE TEAM IS AVAILABLE 24/7 TO PERFORM THERAPEUTIC PLASMA EXCHANGES, CELL DEPLETIONS, OUTPATIENT TRANSFUSION SERVICES, PERIPHERAL BLOOD STEM CELL COLLECTIONS, AND RED CELL EXCHANGES.WASHINGTON CENTER FOR BLEEDING DISORDERSESTABLISHED IN 1974, our TREATMENT CENTER FOR HEMOPHILIA AND BLEEDING DISORDERS OFFERS COMPREHENSIVE SERVICES TO HEMOPHILIA PATIENTS INCLUDING PHYSICIAN AND NURSING CARE AS WELL AS STATEWIDE CLINICS, EDUCATIONAL OUTREACH, COUNSELING, PHYSICAL THERAPY AND HOME INFUSION TRAINING.LABORATORIES AND IMMUNOGENETICSOur MULTIPLE LABS OFFER DIVERSE SERVICES TO HEALTHCARE PROVIDERS. We GENOTYPE AND PHENOTYPE DONOR BLOOD AND PLATELETS FROM THOUSANDS OF DONORS ANNUALLY TO PROVIDE BLOOD THAT IS A "PERFECT MATCH" FOR TRANSPLANT PATIENTS AND FOR PATIENTS WITH COMPLEX BLOOD TYPES. WE PERFORM DIAGNOSTIC TESTING OF PATIENTS WITH BLEEDING DISORDERS, UNDERTAKE CLINICAL TRIAL WORK, PARTNER WITH HOSPITAL TRANSPLANT PROGRAMS, AND SUPPORT INNOVATIVE STUDIES WITH THE BLOODWORKS RESEARCH INSTITUTE.CORD BLOOD PROGRAMBLOODWORKS PARTNERS WITH HOSPITALS ACROSS THE REGION TO RECOVER AND STORE UMBILICAL CORD BLOOD FROM NEW MOTHERS - AN IMPORTANT SOURCE OF STEM CELLS FOR USE IN CANCER TREATMENT, METABOLIC OR IMMUNE SYSTEM DISORDERS, AND RESEARCH. BLOODWORKS CREATED THE FIRST AND ONLY PUBLIC UMBILICAL CORD BLOOD BANK IN THE NORTHWEST, AND HAS PROGRAM PARTNERSHIPS WITH 12 HOSPITALS ACROSS WASHINGTON, OREGON AND HAWAII.BONE MARROW COLLECTIONWORKING IN CONCERT WITH THE NATIONAL MARROW DONOR PROGRAM, BLOODWORKS COORDINATES LAB TESTING, STEM CELL COLLECTION AND FOLLOW-UP WITH REGISTERED DONORS WHO ARE SUPPORTING TREATMENT OF PATIENTS WITH LEUKEMIA AND OTHER LIFE-THREATENING CONDITIONS 13194450 359433 9499314 We are a research Institute with over 70 years of research and discoveries. Bloodworks scientists have transformed patient care with breakthroughs in transfusion medicine, blood biology, blood storage, cancer therapies, organ transplantation, and treatment of clotting disorders. Today, our staff of 70 scientists across 11 laboratories continues to search for new knowledge and new technologies to improve patient care. Bloodworks' scientists can be found in medical schools and at scientific forums sharing the latest blood science with doctors from around the region - and around the world. 160466627 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 150 0 1 1106 1 0 0 0 0 0 1 1 0 0 0 0 0 X 21 20 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 WA OR X Robert Gleason 2066896680 921 Terry Avenue Seattle WA 981041256 Holli Harris Board Chair 1.00 X X 0 0 0 Bill Baldwin Board Vice-Chair 1.00 X X 0 0 0 David Chichester Board Trustee 1.00 X 0 0 0 Katerie Chapman Board Trustee (Through 6/30/17) 1.00 X 0 0 0 Annette E Clark MD JD Board Trustee (Through 1/1/17) 1.00 X 0 0 0 Anne Daffern Board Trustee 1.00 X 0 0 0 Molly Firth Board Trustee 1.00 X 0 0 0 Pat Force Board Trustee 1.00 X 0 0 0 Carla Fowler MD PhD Board Trustee 1.00 X 0 0 0 Jim Garrison Board Trustee 1.00 X 0 0 0 Hunter Graham Goodman JD Board Trustee 1.00 X 0 0 0 Bill Hammond MD Board Trustee 1.00 X 0 0 0 Craig Hendrickson Board Trustee 1.00 X 0 0 0 Mohit Kathuria Board Trustee (Through 6/30/17) 1.00 X 0 0 0 W Conrad Liles MD PhD Board Trustee 1.00 X 0 0 0 Meredith Mathews MD Board Trustee 1.00 X 0 0 0 Jim Palmeri Board Trustee 1.00 X 0 0 0 Sean W Sigmon Board Trustee 1.00 X 0 0 0 Craig Smith MD Board Trustee 1.00 X 0 0 0 Craig M Trewet Board Trustee 1.00 X 0 0 0 Phyllis T Turner-Brim Esq Board Trustee 1.00 X 0 0 0 Bob Wallace Board Trustee 1.00 X 0 0 0 Glenn Wisegarver Board Trustee 1.00 X 0 0 0 James Aubuchon MD President & CEO 40.00 X X 803464 0 42445 Robert Gleason Treasurer & CFO 40.00 X 257281 0 51085 Maxine Sellers Secretary 40.00 X 67800 0 18860 Linda S Barnes Chief Operating Officer 40.00 X 318111 0 41876 Karyn L Denton Vice President Clinical Services 40.00 X 189070 0 30257 Christine Donatelli Chief Quality & Corp Compliance Off 40.00 X 216881 0 39176 Sandra E Linauts Vice President Blood Services 40.00 X 208518 0 34903 Karen Nelson VP Specialty Laboratories 40.00 X 194929 0 28967 Yanyun Wu MD Chief Medical Officer 40.00 X 351370 0 15942 James C Zimring MD Chief Scientific Officer 40.00 X 322538 0 27545 Kirsten Watson Alcorn MD Medical Director 40.00 X 279685 0 28710 Jing-Fei Dong MD Medical Director 40.00 X 229275 0 38858 Barbara A Konkle MD Medical Director 40.00 X 299227 0 32155 Jose A Lopez MD Researcher 40.00 X 327324 0 38600 Sherril J Slichter MD Medical Director 40.00 X 317346 0 35839 Theresa A Nester MEDICAL DIR. (FORMER KEY EMPLOYEE) 40.00 X 219314 0 39250 4602133 0 544468 76 1 1 0 BN Builders Inc 2601 4th Ave Suite 350 Seattle WA 98121 Construction Services 1894317 Robert Half International Inc 2613 Camino Ramon San Ramon CA 94583 Staffing Services 620924 Point B Inc 1420 Fifth Ave Suite 2200 Seattle WA 98101 Consulting Services 528248 Precision Electric Group 15323 NE 90th St Redmond WA 98052 Electrical Services 490114 Ivoxy Consulting Inc 5400 Carillon Point Kirkland WA 98033 Data Services Consulting 449457 34 498050 923409 5500 1421459 SERVICE FEES 541900 96112768 96112768 BLOOD DERIVATIVES 339110 62948678 62948678 RESEARCH REVENUE 541700 9499314 9499314 CTS Management Agreement 531310 1427490 1427490 DELIVERY FEES 480000 421071 421071 5538350 5538350 175947671 1559581 1559581 1378105 1140206 237899 237899 237899 5509699 14041314 5241007 1798772 268692 12242542 12511234 12511234 184651 498050 181739 2912 2912 Joint Venture Investment 621500 -16273 -16273 -16273 191664483 174503908 0 15739116 380546 380546 125964 125964 2468 2468 3136005 1526769 1609236 56663364 48191624 7817228 654512 4053794 3331331 705234 17229 6724253 5718910 927672 77671 4824174 4102912 665539 55723 1044392 681439 362953 120000 120000 99663 99663 77421 77421 249314 249314 4823493 2937116 1566610 319767 1099787 311420 712810 75557 2321741 1825655 447331 48755 4164261 3506180 609611 48470 6329101 5382837 873157 73107 553738 358825 167664 27249 225680 88479 133328 3873 864056 12712 846945 4399 6027360 5126210 831529 69621 861222 732461 118813 9948 DRUGS & SUPPLIES 73418431 73412538 1452 4441 transportation 2620408 2325766 283192 11450 PROVISION FOR BAD DEBT 384465 384465 181195101 160466627 19149281 1579193 35469 29218 2616698 4883104 2556112 2446897 23982724 21420692 2219340 2422739 2094753 2620905 136323966 86065156 49188341 50258810 47492462 61957565 8985737 40641 901750 1118091 140073386 147198662 28524450 26758004 22546457 21581584 3410131 0 54481038 48339588 X 80577237 93885994 1469362 1418831 3545749 3554249 85592348 98859074 140073386 147198662 X 10469382 2795476 1868 X 0 1 X 1 1 1 X 1609433 1259917 11548534 1510536 1421459 17349879 147588876 159648812 161263038 175586838 174503908 818591472 478187 212351 200510 181353 184651 1257052 149676496 161121080 173012082 177278727 176110018 837198403 54169 72760 6879157 502912 276559 7785557 1242940 1242940 54169 72760 8122097 502912 276559 9028497 828169906 2574831 3162201 2693945 2636355 2937686 14005018 2574831 3162201 2693945 2636355 2937686 14005018 152251327 164283281 175706027 179915082 179047704 851203421 0.97290 0.97440 0.01650 0.01500 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 9780 1 14671 0 1 98968 0 0 123419 0 Part II-B, Line 1: During Fiscal Year 2017, Bloodworks had the following state legislative agenda items: 1) In Fiscal 2017 Bloodworks worked with the WA legislature to get a bill passed allowing access to the HOV lanes for the Bloodworks delivery fleet. Bloodworks employees and lobbyists worked with the legislature's transportation committee on the bill. Bloodworks employees conducted a 'day in Olympia' to meet with the Senate and House representatives to garner support for the bill. The bill (Bill S-5837) passed in reduced form and will be resubmitted in 2018. 2) In 2016 Bloodworks worked with the WA legislature to get signed into law a registration requirement with the WA Department of Health for entities who were collecting blood. The intent was to make all entities collecting blood subject to the same stringent licensure imposed by the FDA that blood banks must follow. This bill passed during the 2016 legislative session. On June 23, 2017, the Department of Health adopted a rule that would change the legislative intent of SHB 2580 by allowing hospitals to be exempt from the FDA licensure requirement. Bloodworks is challenging the new Rule. 3625990 8500 165638 3800128 3581374 3545 41071 3625990 446312 3104500 33444 2882 3581374 437267 3400 43322 35416 2261 446312 459879 9143 25153 53991 2917 437267 0.00000 0.93530 0.06470 0 0 2918261 2918261 43275498 23176283 20099215 22413655 13024151 9389504 55996654 45737299 10259355 11719898 4127423 7592475 50258810 X 195548032 2795476 4665 2800141 192747891 249314 -1332722 -1083408 191664483 182281306 4665 1330854 1335519 180945787 249314 249314 181195101 Part V, Line 4: Intended use of endowment fund earnings is for medical research as well as an annual lecture series. Part X, Line 2: THE ORGANIZATION IS A NOT-FOR-PROFIT CORPORATION AND HAS BEEN RECOGNIZED AS TAX-EXEMPT PURSUANT TO SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE EXCEPT TO THE EXTENT OF UNRELATED BUSINESS TAXABLE INCOME AS DEFINED UNDER IRC SECTIONS 511 THROUGH 515. ANY UNRELATED BUSINESS INCOME GENERATED IS NOT SIGNIFICANT; THEREFORE, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED. THE ORGANIZATION HAS ADOPTED ACCOUNTING FOR UNCERTAIN TAX POSITIONS. THE ACCOUNTING STANDARDS PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT PROCESS FOR UNCERTAIN TAX POSITIONS. AS OF JUNE 30, 2017 AND 2016, THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL. Part XI, Line 4b - Other Adjustments: Rental expenses NETTED WITH RENTAL REVENUE -1,140,206. FUNDRAISING FEES NETTED WITH FUNDRAISING REVENUE -176,238. Joint Venture Investment Loss Reclassified to Revenue -14,405. Joint Venture Investment Book/Tax Adjustment -1,868. ROUNDING -5. Part XII, Line 2d - Other Adjustments: Rental expenses NETTED WITH RENTAL REVENUE 1,140,206. FUNDRAISING FEES NETTED WITH FUNDRAISING REVENUE 176,238. Joint Venture Investment Loss Reclassified to Revenue 14,405. Rounding 5. 1 Sub-Saharan Africa 0 0 Grantmaking See Part V 2468 Sub-Saharan Africa 0 0 Program Services Travel to teach safe blood techniques and institute research studies 12550 Europe (including Iceland and Greenland) 0 0 Program Services Travel to meetings regarding blood, transfusion, haemostatis, safety 18679 North America (Canada and Mexico) 0 0 Program Services Travel to meetings regarding blood, transfusion, haemostatis, safety 5186 Europe (including Iceland and Greenland) 0 0 Program Services Publication of Research Article 1632 0 0 0 0 0 0 40515 0 40515 0 0 0 0 0 0 Part I, Line 2: PROCEDURES FOR MONITORING THE USE OF GRANTS AND OTHER ASSISTANCE OUTSIDE THE UNITED STATES INCLUDE REVIEW OF THE SUBRECIPIENT'S FINANCIAL AUDIT AND FOLLOW UP, IF NEEDED, ON ANY FINDINGS. ADDITIONALLY, THERE IS A PROCESS TO REVIEW GENERAL LEDGERS AND WORK CLOSELY WITH THE FINANCIAL DEPARTMENT OF THE SUBRECIPIENT TO ENSURE THAT EXPENSES, INCLUDING SALARY EFFORTS, ARE REASONABLE, PRUDENT, WITHIN THE TERMS OF THE AGREEMENT AND COMPLIANT WITH FEDERAL GUIDELINES. Part I, line 3: Assessing the Role of Improved Pre-transfusion Testing in the Prevention of Alloimmunization in Haemolytic Transfsion Reactions among Ugandans. X X X X X X X 1 del Prodo Philanthropy training & Consulting LLC 5330 89th Ave SE Mercer Island WA 98040 See Part IV 0 0 26813 -26813 M Fitzpatrick Consulting 5737 38th Ave NE Seattle WA 98105 See Part IV 0 0 43100 -43100 Danold A Campbell & Company One East Wacker Drive Suite 2100 CHICAGO IL 60601 See Part IV 0 0 7500 -7500 77413 -77413 WA OR Bloodworks Ball 561651 427075 134576 5500 32097 105526 8720 19548 Swim for Life 79525 29500 50025 1755 107 2917 3 41525 41475 50 3002 1859 708 682701 498050 184651 5500 36854 107492 9428 22465 181739 2912 Part I, Line 2b: del Prodo Philanthropy training & Consulting LLC - Consulting work to fundraise within corporate philantrhropy and initial assessment of portfolio assets for investment. M. Fitzpatrick Consulting - Consulting work for event management and fundraising strategy for auction and charitable gifts. Danold A Campbell & Company - Consulting work for fundraising strategy on major gifts for research support. 1 University of Washington 4333 Brooklyn Avenue NE Seattle WA 98195 916001537 501(c)(3) 136191 See Part IV Baylor College of Medicine PO Box 301207 Dallas TX 75303 741613878 501(c)(3) 125298 Molecular biology, ethnic diversity and disease University of Colorado 13001 E 17th Place Bldg 500 Room W1126 Aurora CO 80045 846000555 501(c)(3) 17724 Biosynthetic and Functional Consequences of Von Willebrand Disease Mutations University of Virginia 1001 North Emmet Street Charlottesvile NC 22904 546001796 501(c)(3) 25858 Serious Hazards of Transfusion & Cellular Therapies: Methods & Intervention Bleeding Disorder Foundation of WA 9639 Firdale Ave Ste A Edmonds WA 98020 916068857 501(c)(3) 75000 Supporting Annual Walk event for foundation education and community outreach 5 0 Research Participants for Blood Studies 388 125964 Part I, Line 2: Monitoring/Review/Procedures: Prior to issuing a subaward, Bloodworks reviews the entity on www.sam.gov for debarment or suspension from receiving Federal funds and confirms the CCR standing of the entity. Grant and Contracts Specialist reviews this information annually. In addition, Bloodworks receives and reviews the annual OMB single audit for our subrecipients and addresses any findings from the audit. The subaward identifies the maximum amount of award and Bloodworks staff verifies that the payments do not exceed this amount. Subrecipients are selected based on the needs of the award and which organization is able to best partner with the Principal Investigator. Part II, line 1: University of Washington Grants: 1. Pilot Safety Study Evaluating Procoagulant Phenotypic Markers of 4/5 Liquid Stored Platelets Transfused into Thrombocytopenic Patients and In Vivo Measurements of Coagulation-related Adverse Events. 2. National Hemophilia Mutation Analysis Project. 3. Biosynthetic and functional consequences of Von Willebrand disease mutations. 4. Integrated Chip-Scale Blood Testing for Transfusion Medicine. 5. A Pilot Study of N-Acetylcysteine in Sickle Cell Disease Vaso-Occlusive Crisis. X X 1 1 X X X X 0 1 0 0 0 0 0 1 0 James Aubuchon MD President & CEO 677090 0 0 0 126374 0 18550 0 23895 0 845909 0 0 0 Robert Gleason Treasurer & CFO 257281 0 0 0 0 0 26500 0 24585 0 308366 0 0 0 Linda S Barnes Chief Operating Officer 318111 0 0 0 0 0 13250 0 28626 0 359987 0 0 0 Karyn L Denton Vice President Clinical Services 189070 0 0 0 0 0 13562 0 16695 0 219327 0 0 0 Christine Donatelli Chief Quality & Corp Compliance Off 216881 0 0 0 0 0 11507 0 27669 0 256057 0 0 0 Sandra E Linauts Vice President Blood Services 208518 0 0 0 0 0 21412 0 13491 0 243421 0 0 0 Karen Nelson VP Specialty Laboratories 194929 0 0 0 0 0 19591 0 9376 0 223896 0 0 0 Yanyun Wu MD Chief Medical Officer 351370 0 0 0 0 0 13250 0 2692 0 367312 0 0 0 James C Zimring MD Chief Scientific Officer 322538 0 0 0 0 0 13250 0 14295 0 350083 0 0 0 Kirsten Watson Alcorn MD Medical Director 279685 0 0 0 0 0 13250 0 15460 0 308395 0 0 0 Jing-Fei Dong MD Medical Director 229275 0 0 0 0 0 15113 0 23745 0 268133 0 0 0 Barbara A Konkle MD Medical Director 299227 0 0 0 0 0 18550 0 13605 0 331382 0 0 0 Jose A Lopez MD Researcher 327324 0 0 0 0 0 25348 0 13252 0 365924 0 0 0 Sherril J Slichter MD Medical Director 317346 0 0 0 0 0 26500 0 9339 0 353185 0 0 0 Theresa A Nester MEDICAL DIR. (FORMER KEY EMPLOYEE) 219314 0 0 0 0 0 22755 0 16495 0 258564 0 0 0 Part I, Line 1a First class travel is provided to the President under very specific and approved circumstances. Social club dues were provided for the President. Social clubs are used for business related meetings. Part I, Line 4b SCHEDULE J, PART I, LINE 4B: BLOODWORKS HAS A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ESTABLISHED TO PROVIDE ADDITIONAL RETIREMENT COMPENSATION TO DR. JAMES AUBUCHON, PRESIDENT AND CEO. As of September 2015 Dr. Aubuchon was fully vested in the plan. For the current year, Dr. Aubuchon received a distribution of $126,374 from the plan. Part I, Line 7 The Board determines and approves the bonuses for the CEO, Dr. AuBuchon. If applicable other employee bonuses are contractually driven by the terms of their employment agreements. Human Resources reviews and maintains employment agreements. Dr. AuBuchon's bonus is at the discretion of the Board. A WA ECONOMIC DEVELOPMENT FINANCE AUTHORITY 911493002 2014-09-15 24140000 PuRCHASE AND RENOVATION OF RENTON, WA FACILITY 0 0 0 A 2558416 24140000 209442 23930558 2009 1 0 1 1 A 0 1 1 1 0 0 0 1 A 0 1 0 0 1 0 0 0 1 A 1 Part II, Line 14 THE PURPOSE OF THIS BOND WAS TO PROVIDE FUNDS FOR A REFUNDING OF BONDS ISSUED AUGUST 14, 2008. Form 990, Part VI, Section B, line 11b Internally, data for the Form 990 is prepared by the Accounting Department and reviewed by the Controller and the Chief Financial Officer. The Form 990 is then prepared by our CPA firm. External review consists of the Form 990 being posted to the Board of Trustee website, and the Board members are emailed a link to this password protected site so that the Form 990 can be reviewed. Form 990, Part VI, Section B, line 12c BLOODWORKS HAS ALL HUMAN RESOURCE POLICIES (INCLUDING CONFLICT OF INTEREST) ONLINE AND ACCESSIBLE. ANY CHANGES ARE HIGHLIGHTED AND SENT TO ALL EMPLOYEES. UPON HIRE AND UPON MAJOR POLICY CHANGES, EMPLOYEE SIGNS ACKNOWLEDGEMENT FORM TO EVIDENCE THAT SHE/HE IS RESPONSIBLE TO READ AND BECOME ACQUAINTED WITH THE POLICIES. ANNUALLY BOARD MEMBERS MUST SIGN A FORM AND DISCLOSE CONFLICTS OF INTEREST. THESE ARE REVIEWED BY THE BOARD CHAIR AND PRESIDENT. If a conflict of interest exists, an interested person may make a presentation, but must leave the meeting during any discussion of the matter. The Chairperson may, if appropriate, appoint a disinterested person to investigate alternatives. The board or committee shall exercise due diligence to determine whether the organization can obtain with reasonable efforts a more advantageous transaction or arrangement that does not create a conflict of interest. Form 990, Part VI, Section B, line 15 The Executive Committee of the Board reviews and approves the President's compensation based on research of other comparable organizations and industry standards performed by a compensation consulting firm. IN 2017 AN OUTSIDE CONSULTING FIRM PROVIDED TRENDS IN BOTH PERFORMANCE INCREASES AND BONUSES FOR CEOS. THE BOARD USED THIS INFORMATION IN THE PRESIDENT'S COMPENSATION REVIEW. Key employees and officers' salaries are reviewed against market data with consideration of internal equity. market data includes annual survey from industry association and comparison to additional regional and national market data approximately every two to three years. In addition, medical staff salaries are reviewed against university ranges for physicians of like specialties. Form 990, Part VI, Section C, line 19 Governing documents and audited financial statements are available upon request. Bloodworks has all human resource policies (including conflict of interest) online and accessible. Form 990, Part XI, line 9: JOINT VENTURE INVESTMENT BOOK/TAX ADJUSTMENT 1,868.